Zhonghan Biomedical Technology (R)-2-(2, 5-difluorophenyl) pyrrolidine preparation method patent was officially authorized

Zhonghan (Qihe County) Biomedical Technology Co., Ltd. welcomed the good news! On June 14, 2024, the State Intellectual Property Office officially issued a notice announcing that the company's patent for a preparation method of (R)-2-(2, 5-difluorophenyl) pyrrolidine has been successfully authorized. Since the application of this patent on February 10, 2022, after a rigorous review and evaluation process, the result was finally received two years later, and the adoption of this patent is also an affirmation of the efforts of the company's research and development personnel.

It is reported that the preparation method patent is the result of many years of efforts by the R&D team of Zhonghan Biomedical Technology Co., LTD., and has significant innovation and practicality. The main application content of the patent includes the use of 2, 5-difluorobenzene as a raw material, combined with a series of fine chemical reaction steps, the method can efficiently and environmentally friendly preparation of high quality (R)-2-(2, 5-difluorophenyl) pyrrolidine, which provides strong support for the production of related fields.

The relevant person in charge of the company said excitedly: "The licensing of this patent is an important milestone in our technological innovation, and also an affirmation of the hard work of our research and development team. In the future, we will continue to adhere to innovation-driven, continue to introduce more high-tech achievements with independent intellectual property rights, and contribute more to the development of the industry!"

In recent years, Zhonghan Pharmaceutical has always adhered to the "innovation-driven" development concept, and is committed to the research and development and production of high-end pharmaceutical intermediates. In the next step, Zhonghan Pharmaceutical will continue to increase investment in research and development, constantly improve the intellectual property protection system, constantly improve the technical level, enhance the ability of independent innovation, and provide more powerful technical support for the high-quality development of enterprises. The patent authorization has not only further enhanced the status and influence of Zhonghan Biomedicine Technology Co., Ltd. in the industry, but also injected a strong impetus for the company's future development. The company believes that under the guidance of innovative technology, under the unremitting efforts of the company team, Zhonghan Biomedical Technology Co., Ltd. will usher in a more brilliant tomorrow!